# A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne

> **NCT06336629** · PHASE4 · COMPLETED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 10 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** Winlevi (clascoterone) 1% & Duac gel

## Key facts

- **NCT ID:** NCT06336629
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-15
- **Primary completion:** 2024-07-10
- **Final completion:** 2024-07-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06336629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06336629, "A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of Acne". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06336629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*